A study led by Isha Jain at Gladstone Institutes found that red blood cells (RBCs) play a crucial role in lowering glucose levels in hypoxic conditions, as they upregulate GLUT1 transporters and metabolize more glucose to produce 2,3-DPG, which aids oxygen release. This discovery highlights the potential for new diabetes therapies targeting RBC metabolism or turnover.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



